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A full-length cDNA clone coding for human mitochondrial dehyde dehydrogenase (ALDH I) was isolated 
from a human fetal muscle cDNA library. Sequence analysis revealed structural similarities between the 
amino-terminal end of ALDH I and other known targeting sequences responsible for protein uptake into 
the mitochondria. 
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1. INTRODUCTION 
Human liver aldehyde dehydrogenase (ALDH, 
EC 1.2.1.3) consists of at least four isozymes. The 
multiple forms of ALDH show a considerable 
heterogeneity in their tissue and organ distribution 
as well as subcellular localization [ 1,2]. ALDH I is 
also referred to in the literature as EZ or ALDH2 
isozyme [2]. Localization of this isoenzyme in the 
mitochondria as well as its assignment to 
chromosome 12 [3,4], suggests the existence of a 
leader peptide directing the protein uptake into the 
mitochondria. Most nuclear coded mitochondrial 
proteins are translated on cytoplasmic polysomes 
at larger precursors containing leader peptides of 
20-60 residues in length at the amino-terminal end 
of the protein [5]. Usually these peptides are 
characterized by the absence of acidic residues and 
an average to above average content of basic 
residues periodically separated by uncharged 
residues [6,7]. Beside these general structural 
similarities, no significant sequence homologies 
were found between mitochondrial presequences. 
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In a recent study, it has been shown that even a 
duplication of a part of the amino-terminal end 
(‘cryptic mitochondrial targeting signal’) of a 
cytosolic protein is sufficient to direct its incor- 
poration into the mitochondria [8]. 
Previously, a partial cDNA clone pEXAL21 
coding for the carboxy-terminal end of ALDH I 
was isolated and characterized from a human liver 
cDNA library [9,10]. Until now, no sequence data 
were available for the amino-terminal end of the 
ALDH I protein. The cDNA clone pEXAL21 was 
chosen to screen a human fetal muscle cDNA 
library in order to isolate a full-length cDNA clone 
and especially to obtain information on the ex- 
treme amino-terminal end. 
2. MATERIALS AND METHODS 
Human fetal muscle RNA was isolated from 
abortion material in the 22nd week of gestation. 
The cDNA library was established in the expres- 
sion vector h gtl 1. RNA isolation and cDNA syn- 
thesis were performed as in [ 111.2 x lo6 pfu of the 
human fetal muscle cDNA library were screened 
using a nick-translated cDNA fragment derived 
from the ALDH I clone pEXAL21. DNA was 
isolated from positive A clones by a small-scale 
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Fig. 1. Partial restriction maps and sequencing strategy 
of the cDNA insert of h cAL1 23. Arrows mark the 
restriction sites sequenced from and the extent of the 
individual sequence determinations. 
T3-RNA-polymerase promotor [ 141 and tran- 
scribed in vitro with and without capping reagent 
(0.1 mM GpppG). The transcription reaction mix- 
ture was placed on ice and 10~1 aliquots were 
directly translated without further purification in a 
rabbit reticulocyte lysate in the presence of 
[35S]methionine. Proteins synthesized were sepa- 
rated on an SDS-polyacrylamide gel and detected 
by fluorography. 
3. RESULTS AND DISCUSSION 
procedure and analyzed further by Southern blot 
hybridization and restriction mapping [ 121. 
The inserts chosen for sequence analysis were 
subcloned in M 13 mp 18 and mp19 and sequenced 
according to Sanger and Coulson [ 131. Full-length 
ALDH I cDNA was subcloned downstream of a 
40 hybridization signals were obtained after 
screening of 2 x lo6 plaques of the human cDNA 
library with a nick-translated ALDH I cDNA frag- 
ment derived from pEXAL21 [3,9]. 24 signals were 
processed through three additional rounds of 
screening until distinct plaques could be isolated. 
Fig.2. Nucleotide sequence of the cDNA insert of h cALI 23 as determined by the strategy outlined in fig.1. 
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MLHAAAAWPAWAPPLVSRRHPGRAAPNOQP 
II II SSSGTPDLPVLLTDL 
Fig.3. Comparison of the first 100 amino acids at the 
amino-terminal ends of ALDH I (upper sequence) and 
ALDH II (lower sequence). 
Two clones with an approximate length of 2 kb 
were sequenced and found to be identical. Fig.1 
shows a limited restriction map of the clone X cAL1 
23 and the sequence strategy. The nucleotide se- 
quence of the cDNA insert of X cAL1 23, which 
corresponds to the entire coding region of ALDH 
I mRNA and the adjacent non-coding regions, is 
shown in fig.2. The nucleotide sequence is in good 
agreement with a previously published partial se- 
quence [15]. The deduced ALDH I amino acid se- 
quence was subsequently compared to the known 
sequence of cytoplasmic isozyme ALDH II [2] in 
order to define the regions forming the mitochon- 
drial signal peptide. As expected considerable 
homology (70%) was observed in the major part of 
the enzyme with exception of the amino-terminal 
end of both proteins (fig.3). The first 20 amino 
acids of ALDH II showed no sequence homology 
to the corresponding ALDH I sequences. Further- 
more, an additional peptide of 15 residues without 
a corresponding counterpart in ALDH II was 
found at the amino-terminal end of ALDH I. 
Based on these observations the whole of the 35 
amino acid amino-terminal end of ALDH I seems 
to represent a mitochondrial leader peptide. 
Similar to other mitochondrial leader sequences 
(fig.4) this peptide is characterized by lack of 
acidic residues and an above average content of 
basic residues typically separated from each other 
by uncharged residues [6,7]. Whether all 35 amino 
acids belong to the leader sequence remains to be 
established. Recently, Hurt et al. 1161 
demonstrated that the first 12 amino acids of an 
imported mitochondrial protein are sufficient to 
direct a cytoplasmic protein into the mitochondrial 
matrix, although most leader peptides sequenced 
so far comprise 20-60 residues. In order to assess 
the actual length of ALDH I signal peptide, in 
vitro studies using recombinant ALDH I protein 
are essential. In pursuance of this goal, the whole 
cDNA insert of h cAL1 23 was subcloned into the 
vector pSP6/T3. This construct was transcribed in 
vitro by Ts-RNA-polymerase, and the resulting 
capped and uncapped mRNAs were translated in a 
cell-free reticulocyte lysate system. The synthesized 
polypeptide migrated similarly to authentic ALDH 
I on SDS-PAGE indicating the absence of major 
posttranslational modifications (fig.5). This pro- 
tein product has an apparent molecular mass of 
50 kDa which is in good agreement with the 
molecular mass of ALDH I monomers [l]. To 
define the critical regions in the putative leader 
peptide, in vitro targeting studies with modified 
ALDH I precursor are in progress. 
+ + ++ + 
ALDH I: MLRAAAAWPAWAPPLVSRRHPGRAAPNQQPEVFCNQ 
+ + + + + + 
CPS I: MTRILTACKVV~~TLKSGFGLANVTSKRQWDFSRPGI~L 
+ + + ++ + + + 
OCT: MLSNLRILLNKAALRKAHTSMVRNFRYGKPVQ 
Fig.4. Comparison of ALDH I leader peptide and presequences found in other mitochondrial precursor proteins. (+ ) 
Basic amino acid, (-) acidic residue. OCT, ornithine carbamyltransferase, CPS I, carbamyl-phosphate synthetase I, 
ALDH I, aldehyde dehydrogenase I.
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Fig.5. In vitro transcription-translation of the precursor 
of ALDH I. A fluorogram of the gel is shown. 
Molecular mass markers are indicated (in kDa). Lanes: 
1, translation products of uncapped ALDH I mRNA; 2, 
translation products of capped ALDH I mRNA; 3, 
without exogenous RNA; 4, translation products of 5 pg 
brome mosaic virus RNA. 
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